
Dr Agarwal's Eye Sees Positive Shift in Market Evaluation Amid Strong Financial Trends
2025-11-29 17:52:00Dr Agarwal's Eye has experienced a notable revision in its market evaluation, reflecting a more favourable analytical perspective. This shift is underpinned by a combination of robust financial trends, technical momentum, and valuation considerations within the hospital sector.
Read MoreIs Dr Agarwal's Eye overvalued or undervalued?
2025-11-28 08:13:19Valuation Metrics and What They Indicate At the heart of any valuation analysis lies the price-to-earnings (PE) ratio, which for Dr Agarwal's Eye stands at 41.45. This figure is significantly higher than the broader market average and indicates that investors are willing to pay a steep premium for each rupee of earnings. Complementing this, the price-to-book (P/B) ratio of 8.30 further underscores the market's elevated expectations, suggesting that the stock is trading well above its net asset value. Enterprise value multiples also paint a similar picture. The EV to EBIT ratio is nearly 31, while the EV to EBITDA ratio is above 21, both of which are considerably high for the hospital sector. These multiples imply that the market anticipates robust future earnings growt...
Read More
Dr Agarwals Eye Hospital Valuation Shifts Highlight Changing Market Dynamics
2025-11-28 08:00:37Dr Agarwals Eye Hospital has experienced notable shifts in its valuation parameters, reflecting evolving market perceptions within the hospital sector. Recent data reveals adjustments in key metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV), positioning the stock in a different valuation category compared to its historical averages and peer group.
Read MoreWhy is Dr Agarwal's Eye falling/rising?
2025-11-28 00:23:57Recent Price Movement and Market Context The stock demonstrated a strong reversal today, opening with a gap up of 2.78% and reaching an intraday high of ₹5,579.90, marking an 8.21% increase from the previous close. This performance outpaced its sector by 5.54%, signalling a clear outperformance relative to peers. Notably, the stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a positive technical trend and underlying momentum. Investor participation has also increased, with delivery volumes on 26 Nov rising by 39.74% compared to the five-day average, suggesting heightened buying interest. Liquidity remains adequate, supporting trade sizes of up to ₹0.01 crore without significant price impact.</...
Read More
Dr Agarwals Eye Hospital Hits Intraday High with Strong 7.44% Surge
2025-11-27 13:07:21Dr Agarwals Eye Hospital demonstrated robust intraday performance on 27 Nov 2025, reaching an intraday high of Rs 5,539.95, reflecting a 7.44% rise from the previous close. The stock outpaced its sector and broader market indices, marking a notable rebound after a sequence of declines.
Read More
Dr Agarwals Eye Hospital Sees Shift in Technical Momentum Amid Mixed Market Signals
2025-11-26 08:05:55Dr Agarwals Eye Hospital's stock has experienced a notable shift in technical momentum, reflecting a complex interplay of bullish and bearish signals across various timeframes. While daily moving averages indicate a positive trend, monthly indicators present a more cautious outlook, underscoring the nuanced market assessment of this hospital sector player.
Read More
Dr Agarwals Eye Hospital Sees Mixed Technical Signals Amid Price Momentum Shift
2025-11-24 08:03:34Dr Agarwals Eye Hospital's stock has experienced a nuanced shift in price momentum, reflecting a complex interplay of technical indicators across multiple timeframes. Recent evaluation adjustments highlight a transition from a bullish to a mildly bullish trend, with key metrics such as MACD, RSI, and moving averages offering a varied outlook for investors navigating the hospital sector.
Read MoreIs Dr Agarwal's Eye technically bullish or bearish?
2025-11-19 08:15:03As of 18 November 2025, the technical trend has changed from mildly bullish to bullish. The current technical stance is bullish with moderate strength. Key indicators driving this stance include a bullish MACD on the weekly timeframe, bullish Bollinger Bands on both weekly and monthly timeframes, and bullish moving averages on the daily timeframe. However, the monthly MACD and KST are mildly bearish, indicating some caution. The RSI shows a bullish signal on the monthly but no signal on the weekly. Overall, while there are mixed signals in the longer-term indicators, the prevailing trend is bullish....
Read More
Dr Agarwals Eye Hospital Technical Momentum Shifts Signal Market Interest
2025-11-19 08:07:06Dr Agarwals Eye Hospital has exhibited a notable shift in its technical parameters, reflecting a change in price momentum and market sentiment. The stock, currently priced at ₹5,250.00, shows a mild bullish trend on weekly charts and a more pronounced bullish stance on daily moving averages, signalling evolving investor interest within the hospital sector.
Read MoreBoard Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025
28-Jan-2026 | Source : BSEDr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve the unaudited financial results for the quarter and nine months ended December 31 2025.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
12-Jan-2026 | Source : BSEAs per the letter enclosed.
Closure of Trading Window
26-Dec-2025 | Source : BSEAs per the letter enclosed
Corporate Actions
No Upcoming Board Meetings
Dr Agarwals Eye Hospital Ltd has declared 30% dividend, ex-date: 07 Nov 25
No Splits history available
No Bonus history available
No Rights history available